COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS

Objective: To compare oral Azithromycin with oral Doxycycline in treatment of moderate Acne Vulgaris. Study design: Randomized control trial Place and duration of the study: Dermatology Department , Pak Emirates Military Hospital, Rawalpindi from 1st August 2017 till 31st January 2018. Mate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Muhammad Mudassir, Ali Amar, Naeem Raza, Ayesha Khokhar, Adeel Siddiqui, Najia Ahmed
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2021
Materias:
R
Acceso en línea:https://doi.org/10.51253/pafmj.v71iSuppl-1.2926
https://doaj.org/article/a8638e9414334277a311cac1f8c18827
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a8638e9414334277a311cac1f8c18827
record_format dspace
spelling oai:doaj.org-article:a8638e9414334277a311cac1f8c188272021-12-02T19:11:53ZCOMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIShttps://doi.org/10.51253/pafmj.v71iSuppl-1.29260030-96482411-8842https://doaj.org/article/a8638e9414334277a311cac1f8c188272021-01-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/2926https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To compare oral Azithromycin with oral Doxycycline in treatment of moderate Acne Vulgaris. Study design: Randomized control trial Place and duration of the study: Dermatology Department , Pak Emirates Military Hospital, Rawalpindi from 1st August 2017 till 31st January 2018. Materials and methods: A total of 92 patients with moderate Acne were selected from Dermatology outpatient department (OPD) Pak Emirates Military Hospital Rawalpindi, after written informed consent. Patients were randomly allocated to one of the two treatment groups: Group A and Group B by lottery method. Patients in group A were given oral Azithromycin 500 mg daily for four consecutive days each month for 03 months and patients in group B were given oral Doxycycline 100 mg daily for 03 months. Patients were reviewed monthly for 03 months and Acne Severity Index (ASI) was recorded at baseline, at one month and three months. The primary outcome measured was more than 50% decrease from baseline in ASI within 3 months of treatment, using Global Acne Grading System (GAGS). Results: Mean age of patients in group A was 21.80 + 4.64 years whereas mean age of patients in group B was 21.61 + 4.48 years. In group A mean pre-treatment ASI was 24.83 + 3.15 and mean post-treatment ASI was 10.15 + 1.7. In group B mean pre-treatment ASI was 25.30 ± 2.96 and mean post-treatment ASI was 9.86 + 1.58. Conclusion: Azithromycin is comparable to Doxycycline in terms of mean change in ASI, in the treatment of moderate Acne Vulgaris.Muhammad MudassirAli AmarNaeem RazaAyesha KhokharAdeel SiddiquiNajia AhmedArmy Medical College Rawalpindiarticlemoderate acne vulgarisazithromycindoxycyclineacne severity indexMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 71, Iss SUPPL-1, Pp 268-272 (2021)
institution DOAJ
collection DOAJ
language EN
topic moderate acne vulgaris
azithromycin
doxycycline
acne severity index
Medicine
R
Medicine (General)
R5-920
spellingShingle moderate acne vulgaris
azithromycin
doxycycline
acne severity index
Medicine
R
Medicine (General)
R5-920
Muhammad Mudassir
Ali Amar
Naeem Raza
Ayesha Khokhar
Adeel Siddiqui
Najia Ahmed
COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
description Objective: To compare oral Azithromycin with oral Doxycycline in treatment of moderate Acne Vulgaris. Study design: Randomized control trial Place and duration of the study: Dermatology Department , Pak Emirates Military Hospital, Rawalpindi from 1st August 2017 till 31st January 2018. Materials and methods: A total of 92 patients with moderate Acne were selected from Dermatology outpatient department (OPD) Pak Emirates Military Hospital Rawalpindi, after written informed consent. Patients were randomly allocated to one of the two treatment groups: Group A and Group B by lottery method. Patients in group A were given oral Azithromycin 500 mg daily for four consecutive days each month for 03 months and patients in group B were given oral Doxycycline 100 mg daily for 03 months. Patients were reviewed monthly for 03 months and Acne Severity Index (ASI) was recorded at baseline, at one month and three months. The primary outcome measured was more than 50% decrease from baseline in ASI within 3 months of treatment, using Global Acne Grading System (GAGS). Results: Mean age of patients in group A was 21.80 + 4.64 years whereas mean age of patients in group B was 21.61 + 4.48 years. In group A mean pre-treatment ASI was 24.83 + 3.15 and mean post-treatment ASI was 10.15 + 1.7. In group B mean pre-treatment ASI was 25.30 ± 2.96 and mean post-treatment ASI was 9.86 + 1.58. Conclusion: Azithromycin is comparable to Doxycycline in terms of mean change in ASI, in the treatment of moderate Acne Vulgaris.
format article
author Muhammad Mudassir
Ali Amar
Naeem Raza
Ayesha Khokhar
Adeel Siddiqui
Najia Ahmed
author_facet Muhammad Mudassir
Ali Amar
Naeem Raza
Ayesha Khokhar
Adeel Siddiqui
Najia Ahmed
author_sort Muhammad Mudassir
title COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
title_short COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
title_full COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
title_fullStr COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
title_full_unstemmed COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
title_sort comparison of monthly pulse of oral azithromycin with daily doxycycline in the treatment of moderate acne vulgaris
publisher Army Medical College Rawalpindi
publishDate 2021
url https://doi.org/10.51253/pafmj.v71iSuppl-1.2926
https://doaj.org/article/a8638e9414334277a311cac1f8c18827
work_keys_str_mv AT muhammadmudassir comparisonofmonthlypulseoforalazithromycinwithdailydoxycyclineinthetreatmentofmoderateacnevulgaris
AT aliamar comparisonofmonthlypulseoforalazithromycinwithdailydoxycyclineinthetreatmentofmoderateacnevulgaris
AT naeemraza comparisonofmonthlypulseoforalazithromycinwithdailydoxycyclineinthetreatmentofmoderateacnevulgaris
AT ayeshakhokhar comparisonofmonthlypulseoforalazithromycinwithdailydoxycyclineinthetreatmentofmoderateacnevulgaris
AT adeelsiddiqui comparisonofmonthlypulseoforalazithromycinwithdailydoxycyclineinthetreatmentofmoderateacnevulgaris
AT najiaahmed comparisonofmonthlypulseoforalazithromycinwithdailydoxycyclineinthetreatmentofmoderateacnevulgaris
_version_ 1718377108405747712